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Abstract 
BACKGROUND: Matrix metalloproteinase 9 (MMP-9) is involved in extracellular matrix 
degradation and remodeling. An increase in MMP-9 expression by vascular component cells 
plays an important role in atherosclerotic plaque formation and rupture. Resveratrol, a 
polyphenolic substance, was suggested to play a role in preventing the progress of 
atherosclerotic disease. The aim of this study was to investigate the effect of resveratrol on 
MMP-9 and tissue inhibitors of metalloproteinases (TIMPs) in vascular smooth muscle cells 
(VSMCs) after treatment with H2O2. 
METHODS: Cultured VSMCs were pre-treated with 0.2 mM of H2O2 before stimulation with 
different concentration of resveratrol. Expression of MMP-9, TIMP-1, and TIMP-3 genes were 
measured using real-time polymerase chain reaction (PCR) method, and MMP-9 protein level 
was detected using western blot analysis. 
RESULTS: Resveratrol at 120 μmol/l concentration reduced the elevated level of MMP-9 induced 
by H2O2 in VSMCs as 1.85 ± 0.35 folds (P < 0.050) and 8.70 ± 1.20 folds (P < 0.050) after 24 
and 48 hours, respectively. Resveratrol increased the diminished level of TIMP-1 induced by 
H2O2 as 2.5 ± 0.48 folds following the treatment with 120 μmol/l after 48 hours (P < 0.050). 
CONCLUSION: Resveratrol as an antioxidant can decrease MMP-9 production, not only by 
suppressing MMP-9 expression, but also by augmenting TIMP-1 production. Altogether, 
resveratrol as an antioxidant can regulate the MMP-9/TIMP-1 balance, and may be considered 
as a preservative agent in the treatment and prevention of atherosclerosis. 
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Introduction 
Atherosclerosis is the most common cause of death 
in the world, and oxidative stress has a critical role 
in the pathogenesis and development of 
atherosclerosis. Matrix metalloproteinase 9 (MMP-
9) is a member of the family of endopeptidases, that 
is involved in extracellular matrix degradation and 
remodeling. Increased expression of MMP-9 by 
vascular component cells during vascular injury and 
inflammation plays an important role in 
atherosclerotic plaque formation and rupture.1  
MMPs activity is regulated by tissue inhibitors of 
metalloproteinases (TIMPs).2 Changes in TIMP 
levels are considered to be important due to their 
direct effect on MMP activity. Resveratrol is a 
natural polyphenolic antioxidant, and several studies 
have confirmed its protective effects on the 
cardiovascular system in patients with coronary 
artery disease (CAD).3,4 
Resveratrol has a cardioprotective activity via 
various mechanisms such as anti-inflammatory and 
antioxidant activity.5,6 
Resveratrol reduces neural damage after cerebral 
ischemia. The elevated levels of MMP-9 were 
notably diminished in the resveratrol-treated mice as 
compared to the vehicle MCAO mice; suggesting 
that resveratrol can protect neural tissue against 
acute ischemic stroke, which could be attributed to 
its activity against MMP-9 by inhibiting JNK and 
PKC signal transduction.7,8 
It seems that inhibition of MMPs activation or 
prevention of their upregulation could inhibit the 
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effects of oxidative stress on atherosclerotic plaque 
formation. The aim of this study was to investigate 
the effect of resveratrol on MMP-9 and TIMPs in 
vascular smooth muscle cells (VSMCs) after 
treatment with H2O2. 
Materials and Methods 
In this experimental study, human aorta-vascular 
smooth muscle cells (HA-VSMC) were purchased 
from cell bank of Pasteur Institute of Iran in 
Tehran, Iran. The cells were cultured in F12K 
growth medium. F12K media contained 10% fetal 
bovine serum (FBS), 0.05 mg/ml ascorbic acid, 0.01 
mg/ml insulin, 0.05 mg/ml transferrin, 10 ng/ml 
sodium selenite, 0.03 mg/ml human epidermal 
growth factor (EGFs), 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid (HEPES) to a final 
concentration of 10 mM, penicillin (100 U/ml), and 
streptomycin (100 U/ml).  
Cells were cultured in a humidified incubator 
containing 5% CO2 at 37 °C. Daily control of cell 
growth and cell division in culture condition were 
done. Cells used for the experiments were 3 to  
7 passages.   
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide (MTT) assay was used to determine 
resveratrol concentration causing 50% cell death 
(the half maximal inhibitory concentration or IC50). 
Briefly, the cells were seeded at a density of 15 × 
103 in 96-well plates. After achieving approximately 
80% confluence, cells were treated with increasing 
concentration of resveratrol (40 to 200 μmol/l) for 
48 hours. Thereafter, 20 μl MTT (5 mg/ml, Sigma-
Aldrich, Germany) solution was added to each well. 
The formazan crystal was dissolved by adding 150 
μl dimethyl sulfoxide (DMSO) to each well after  
4 hours, and the optical density of each well was 
measured at 490 nm on an enzyme-linked 
immunosorbent assay (ELISA) plate reader 
(Awareness, USA) following 4 hours of incubation 
at 37 ˚C.  
The cells were seeded in a 12-well plate at a 
density of 1 × 104 cells per well. When the cells 
achieved approximately 80% confluence, they were 
pretreated with physiologic concentration (0.2 mM) 
of H2O2 for inducing oxidative stress.9 Then, the 
cells co-cultured with 80, 100, and 120 μmol/l 
resveratrol (Sigma, USA) for 24 and 48 hours. 
RNA isolation and cDNA synthesis: Total RNA 
was extracted from the cells using Trizol (Invitrogen, 
USA) according to the manufacturer instructions. RNA 
was quantified using a Nanodrop 2000C 
spectrophotometer (Thermo Scientific, USA) and 
treated with DNase. Then, cDNA was synthesized 
from 0.5 mg total RNA using random primer and the 
cDNA Synthesis kit (Thermo Fisher Scientific, USA). 
Real-time polymerase chain reaction (Real-
time PCR): The expression of MMP-9, TIMP-1, 
and TIMP-3 genes was measured using quantitative 
real-time PCR. The experiments were performed 
using Rotor-Gene 3000 real-time DNA 
amplification system (Corbett Research, Australia) 
and SYBR green method. Primers used for real-time 
PCR are listed in table 1. Experiments were 
performed in triplicate,6 using 5 µl SYBR green 
PCR Master Mix, 0.2 µl primer sets, 2 µl cDNA  
(40 ng), and 3.6 µl nuclease-free H2O to yield a  
10 µl reaction. The amplification conditions were as 
follow: initial denaturing at 94 °C for 5 minutes, 
then 40 cycles of 95 °C for 15 seconds, 59 °C for  
20 seconds, and 72 °C for 30 seconds. The 
comparative cycle threshold (CT) (ΔΔCT) method 
was used for data quantitation, and glyceraldehyde-
3-phosphate dehydrogenase (GAPDH) gene 
expression was used as an endogenous reference. 
 
Table 1. Primer sequences and product length 
Genes Genes Primer sequences (5'-3') 
Amplicon 
length (bp) 
Gene bank 
reference 
MMP-9 Forward: GCTCACCTTCACTCGCGTGTA 
Reverse: TCCGTGCTCCGCGACA 
70 NM_004994.2 
TIMP-1 Forward: CCTGGCTTCTGGCATCCTG 
Reverse: CCACGAACTTGGCCCTGATG 
125 NM_003254.2 
TIMP-3 Forward: GTCGCGTCTATGATGGCAAG 
Reverse: AAGCAAGGCAGGTAGTAGCA 
151 NM_000362.4 
GAPDH Forward: ACACCCACTCCTCCACCTTTG 
Reverse: TCCACCACCCTGTTGCTGTAG 
112 NM-002046.5 
MMP-9: Matrix metalloproteinase 9;TIMP: Tissue inhibitors of metalloproteinases; GAPDH: Glyceraldehyde-3-phosphate 
dehydrogenase  
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Western blot analysis: Western blot analysis 
was used for detecting MMP-9 protein expression. 
VSMCs were lysed in ice-cold radioimmune 
precipitation assay buffer (6 ×) containing protease 
inhibitor cocktail. Samples were electrophoresed on 
12% sodium dodecyl sulfate polyacrylamide gel 
electrophoresis (SDS-PAGE). The separated 
proteins were transferred to nitrocellulose 
membranes, and incubated overnight at 4 °C with 
blocking solution [5% nonfat dried milk in 
phosphate-buffered saline (PBS) containing 0.1% 
Tween 20]. Membranes were incubated with MMP-
9 antibody (1:3000) at room temperature for  
2 hours. After washing, the membrane was 
incubated with goat anti-rabbit IgG horseradish 
peroxidase conjugate (1:10,000) at room 
temperature for 90 minutes. Finally, the color was 
developed with the addition of 3,3’,5,5’-tetramethyl-
benzidine membrane peroxidase substrate. Beta-
actin was detected as a sample loading control. 
All experiments were done in triplicate. Results 
are expressed as the mean ± standard error of mean 
(SEM). Statistical analysis was done using 
nonparametric Kruskal-Wallis test. The 
nonparametric Mann-Whitney U test was used to 
compare differences between control and test 
groups. P value of less than 0.050 was considered as 
the level of significance. 
Results 
The IC50 of resveratrol estimated by MTT assay 
was about 120 μmol/l. This concentration of 
resveratrol was chosen for further experiments. 
In this study, the resveratrol effects on 
expression of MMP-9 and its inhibitors (TIMP-1 
and -3) were investigated in VSMCs after inducing 
with H2O2. H2O2 used at the non-toxic 
concentration of 0.2 mM. MMP-9 expression 
increased 1.43 ± 0.29 and 1.98 ± 0.54 folds after  
24 and 48 hours, respectively (P < 0.050 for both) 
after treatment of the cells with H2O2 without 
resveratrol. In contrast, resveratrol at different 
concentrations decreased MMP-9 expression, when 
given simultaneously with H2O2.  
After 24 hours, MMP-9 expression was 
decreased 1.60 ± 0.21, 1.57 ± 0.30, and 1.85 ± 0.35 
folds following the treatment with 80, 100, and  
120 μmol/l resveratrol when compared with the 
H2O2-treated group (P < 0.050 for all) (Figure 1).  
After 48 hours, resveratrol at 80, 100, and  
120 μmol/l concentrations reduced the elevated 
level of MMP-9 induced by H2O2 as 6.20 ± 1.28,  
5.50 ± 1.96, and 8.70 ± 1.20 folds, respectively, 
when compared with the H2O2-treated group  
(P < 0.050 for all) (Figure 1). 
 
 
Figure 1. H2O2 upregulated the expression of matrix 
metalloproteinase 9 (MMP-9) in vascular smooth 
muscle cells (VSMCs). Resveratrol at 80, 100, and 120 
μmol/l concentrations reduced the elevated level of 
MMP-9 induced by H2O2.  
* P < 0.050 compared with control group 
# P < 0.050 compared with H2O2-treated group 
 
Western blot analysis confirmed the changes 
observed at MMP-9 mRNA level (Figure 2). In 
western blot analysis, beta-actin (42 kDa) was used 
as internal control. 
 
 
Figure 2. The expression of matrix metalloproteinase  
protein 9 (MMP-9) determined by western blot 
analysis after treatment with 80, 100, 120 μmol/l 
resveratrol in vascular smooth muscle cells (VSMCs). 
Beta-actin (42 kDa) was used as an internal control to 
standardize the protein loading in western blotting.  
Lane 1: control; Lane 2: treated with H2O2; Lane 3-5: treated 
with H2O2 and various concentration of resveratrol (80, 100, 
and 120 μmol/l, respectively). 
 
After treating the cells with H2O2 without 
resveratrol, TIMP-1 expression decreased 1.73 ± 0.26 
folds after 48 hours (P < 0.050). In contrast, 
resveratrol at different concentrations increased 
TIMP-1 expression when given simultaneously  
with H2O2. 
After 48 hours, resveratrol at 80, 100, and  
120 μmol/l concentrations increased the diminished 
level of TIMP-1 induced by H202 about 1.74 ± 0.51, 
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1.93 ± 0.37, and 2.50 ± 0.48 folds, respectively, 
compared with the H2O2-treated group (P < 0.050 
for all) (Figure 3). There was no significant change 
in the expression of TIMP-1 after 24 hours. 
 
 
Figure 3. H2O2 downregulated the expression of tissue 
inhibitors of metalloproteinase 1 (TIMP-1) in vascular 
smooth muscle cells (VSMCs). Resveratrol in 80, 100, 
and 120 μmol/l concentrations increased the diminished 
level of TIMP-1 induced by H2O2 after 48 hours.  
* P < 0.050 compared with control group 
# P < 0.050 compared with H2O2-treated group 
 
We found no significant effect by resveratrol on 
TIMP-3 expression by real time PCR (not shown). 
Discussion 
In this study, we investigated the resveratrol effect 
on MMP-9 expression in H2O2-induced VSMCs. 
Resveratrol decreased MMP-9 expression in H2O2-
induced VSMCs. 
Matrix metalloproteinases play important roles 
in cardiovascular diseases, and oxidative stress has 
destructive effect on vascular biology through the 
activation of MMPs.10  
MMP-9 is involved in the breakdown of 
extracellular matrix proteins in various physiological 
and pathological conditions, such as angiogenesis, 
bone development, and atherosclerosis plaque 
rupture.1  
Enhanced expression and activities of MMP-9 
have been observed in vascular injury. TIMP-1 is 
endogenous inhibitor of MMP-9, and it is suggested 
that TIMP-1 plays an important role in 
cardiovascular disease. 
Regarding the effects of oxidative stress in 
vascular remodeling, antioxidant approaches are 
used to reduce the upregulation of MMPs, and 
attenuate the tissue dysfunction and remodeling 
during vascular diseases.11-13 
In this study, H2O2 increased MMP-9 expression 
in VSMCs. Upregulation of MMP-9 is not 
unexpected in conditions that free radicals were 
increased by H2O2 or other oxidants. Elevated 
levels of MMP-9 due to oxidant stress in VSMCs 
has been demonstrated in many studies.10,14 
Resveratrol decreased MMP-9 expression in 
H2O2-induced VSMCs. Resveratrol displays potent 
antioxidant activity, thereby can scavenge free 
radicals produced by H2O2, and so reduce the 
oxidative effects of H2O2 in the environment. 
Previous studies have demonstrated that 
polyphenols interfere with MMP-9 expression, and 
reduce inflammatory angiogenesis through MMP-9 
inhibition.15,16 The results of this study and other 
studies17,18 support a potential protective role for 
dietary polyphenols in cardiovascular diseases. 
Resveratrol inhibits the nuclear factor kappa-
light-chain-enhancer of activated B cells (NF-κB) 
signal transduction pathway that mediates the 
expression of MMPs and many other genes 
involved in inflammatory and pro-oxidant processes 
associated with vascular disease development.19 The 
capability of resveratrol in reducing of NF-κB 
activity may be considered indicative to change 
MMP-9 expression in this study. 
The MMPs are tightly regulated, not only at the 
transcriptional level, but also by their specific 
inhibitors.20,21 The effect of antioxidant on MMP or 
TIMP expression in different cells has been 
previously reported.22-24 
Epigallocatechin-3-gallate, as an antioxidant 
agent, reduces the activity and expression of MMP-
9, and enhances the expression of TIMP-1 in cancer 
cell line MDA-MB-231.22 
In a recent study, resveratrol attenuated blood-
brain barrier dysfunction via regulation of MMP-9 
and TIMP-1.23 
According to a study, use of polyphenol extract 
from olive pomace oil down-regulated the levels of 
matrix MMP-2 and MMP-9, and increased TIMP-1 
expression in human endothelial cells,24 which could 
represent a powerful tool for the prevention and 
treatment of endothelial dysfunction-associated 
vascular disease. 
Matrix metalloproteinases contribute to plaque 
rupture, atherothrombosis, and myocardial 
infarction.25 For this reason, using MMP inhibitors 
can be considered as a preservative agent for the 
prevention and treatment of cardiovascular 
diseases.26 
The results of this study showed that resveratrol, 
as an antioxidant, can decrease MMP-9 expression, 
# 
* 
# 
# 
# 
0.00
0.20
0.40
0.60
0.80
1.00
1.20
1.40
1.60
F
o
ld
 C
h
a
n
g
e
 
24 hours 48 hours
  
 
http://arya.mui.ac.ir 15 July 
 Farrokhi, et al. 
 ARYA Atheroscler 2018; Volume 14; Issue 4    161 
not only by suppressing MMP-9 production, but 
also by augmenting TIMP-1 production. 
It seems that due to the dual role of resveratrol 
with regard to regulation of the MMP-9/TIMP-1 
balance, it could be a good choice for preventing 
and treating cardiovascular diseases. 
Conclusion 
Altogether, the results of this study showed that 
resveratrol, as an antioxidant, can regulate the 
MMP-9/TIMP-1 balance, and may be considered as 
a preservative agent in the prevention and treatment 
of atherosclerosis. To better understand the 
atherosclerosis prevention and treatment with 
resveratrol, further studies with animal models  
are necessary. 
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